Search Results for Bristol-Myers Squibb

Showing 1 – 4

Asia Regulatory Roundup: CFDA Offers Guidance on Device Quality Control (10 January 2017) By Nick Paul Taylor - Published 10 January 2017

Welcome to our Asia Regulatory Roundup, our weekly overview of the top regulatory news in Asia.

Categories: News, Asia, CDSCO, CFDA, PMDA, Biologics and biotechnology, Drugs, Medical Devices

Tags: AstraZeneca, Bristol-Myers Squibb, Merck, CDSCO, codeine

FDA Approves Modified Dosing Regimen for Bristol-Myers Squibb’s Cancer Treatment Opdivo By Zachary Brennan - Published 15 September 2016

The US Food and Drug Administration (FDA) this week agreed to modify the dosage regimen for Bristol-Myers Squibb’s cancer treatment Opdivo (nivolumab) for the currently approved indications for renal cell carcinoma, metastatic melanoma and non-small cell lung cancer. 

Categories: News, US, FDA, Biologics and biotechnology, Compliance, Drugs, Due Diligence, Labeling

Tags: Opdivo, Bristol-Myers Squibb, Opdivo dosing

B-MS Pays $14M to Settle SEC Charges over Bribing Health Providers in China By Zachary Brennan - Published 05 October 2015

Bristol-Myers Squibb (B-MS) on Monday agreed to pay more than $14 million to the Securities and Exchange Commission (SEC) to settle charges that its joint venture in China made cash payments and provided other benefits to health care providers (HCPs) at state-owned and state-controlled hospitals in exchange for prescription sales.

Categories: News, China, US, DOJ, Audit, Biologics and biotechnology, Drugs, Due Diligence, Ethics, Government affairs, Regulatory intelligence

Tags: China, Bristol-Myers Squibb, SEC, FCPA, bribery

Untitled Letter Cites BMS for Alleged Misbranding By Alexander Gaffney - Published 18 July 2012

Tags: OPDP, Sales Aid, Ixempra, Bristol-Myers Squibb, Untitled Letter, BMS, Latest News, marketing